ESC 365 - The effect of sildenafil on maternal mortality in pulmonary arterial hypertension associated with congenital heart disease

ESC Professional Premium Access

The effect of sildenafil on maternal mortality in pulmonary arterial hypertension associated with congenital heart disease

Session: Current treatment of pulmonary hypertension: it is all about vasodilators

Topic: Pharmacotherapy

Speaker: Mrs N. Nahdi (Yogyakarta, ID)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Mrs Nabila Sabri Nahdi

Sardjito hospital, Yogyakarta (Indonesia)

0 follower

7 more presentations in this session

Effect of a short course of parenteral treprostinil therapy on right heart structure and function in pulmonary arterial hypertension

Speaker: Doctor C. Vizza (Rome, IT)

Triple therapy for incident pulmonary arterial hypertension in Finland between 2008 and 2020. A descriptive real-world FINPAH cohort study

Speaker: Doctor M. Pentikainen (Helsinki, FI)

Macitentan tadalafil Fixed Dose Combination (FDC) in treatment-naive and prior monotherapy patients with Pulmonary Arterial Hypertension (PAH): insights from A DUE

Speaker: Professor P. Jansa (Prague, CZ)

Efficacy comparison of prostacyclin analogue and prostacyclin receptor agonist as third line treatment for pulmonary arterial hypertension

Speaker: Doctor G. martini (Bologna, IT)

Specific therapies of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database.

Speaker: Doctor A. Mamzer (Lodz, PL)

Access the full session

Current treatment of pulmonary hypertension: it is all about vasodilators

Speakers: Mrs N. Nahdi, Doctor C. Vizza, Doctor M. Pentikainen, Professor P. Jansa, Doctor G. martini...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources